olmesartan medoxomil
- RxCUI
- 118463
- RxNorm name
- olmesartan medoxomil
- Term type
- PIN
- Status
- Active
- Updated
- 2026-10-24 12:44:48
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| olmesartan | 321064 |
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_Rx | e64c3b3b-d5e7-6d46-e053-2a95a90a1b64 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | direct rx | b57e47a5-43e0-d1c5-e053-2a95a90a2b07 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Aurobindo Pharma Limited | 8c94d403-809b-43b9-834f-3ecd330d2dd9 | 2025-01-04 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Proficient Rx LP | eff8b514-bb7f-427e-a267-7dee25fff611 | 2024-11-01 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Lannett Company, Inc. | c620361a-dc2d-28a1-e053-2995a90abd14 | 2024-10-29 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Rising Pharma Holdings, Inc. | b02ff20e-3f0e-43f4-a7b5-6ce56295d023 | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_Rx | 16754802-d5a4-0350-e063-6394a90aa967 | 2024-09-26 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 8a021ffc-8b11-4ddf-81c4-87515971fdee | 2024-08-27 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | a4ceea38-8fff-4317-be04-8dc22222ec70 | 2024-08-27 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | afcfc1eb-29b1-46e8-a013-5cbb1737a232 | 2024-08-15 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Cadila Pharmaceuticals Limited | c5416a9f-1dcc-4851-bbc0-6664d22fc8fa | 2024-08-05 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 879630ff-662a-40bd-b74f-a864661dea95 | 2024-06-13 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 25431c8c-9f6e-42e7-ab84-4b062755bfe3 | 2024-05-29 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | QUALLENT PHARMACEUTICALS HEALTH LLC | 98f930d5-f7c2-4870-92b4-0ad37ce45797 | 2024-05-14 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Direct_Rx | 16752f60-655a-f727-e063-6394a90a96b6 | 2024-04-19 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | fe80fd21-fa8d-474e-ac0a-23f0e1eb7f3b | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | c35408d2-a4b5-43de-8dab-f74a60fa9853 | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| Olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Novadoz Pharmaceuticals LLC | 4238a064-1bfd-4ce3-b9d9-12c96eee8af0 | 2023-11-30 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | b55b6172-d986-4fd9-ba85-a8393c908949 | 2023-11-07 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | Inventia Healthcare Limited | 05a807bf-5175-43a2-a676-215bba2645a8 | 2023-09-15 | Boxed warning, Warnings, Adverse reactions | OLMESARTAN MEDOXOMIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C09CA | Angiotensin II receptor blockers (ARBs), plain | ATC1-4 | olmesartan medoxomil | |
| FDASPL | N0000175561 | Angiotensin 2 Receptor Blocker | EPC | has_epc | olmesartan |
| FDASPL | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan |
| MEDRT | D007093 | Imidazoles | CHEM | has_ingredient | olmesartan |
| MEDRT | D000068557 | Olmesartan Medoxomil | CHEM | has_ingredient | olmesartan medoxomil |
| MEDRT | D013777 | Tetrazoles | CHEM | has_ingredient | olmesartan |
| MEDRT | D003928 | Diabetic Nephropathies | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D003928 | Diabetic Nephropathies | DISEASE | may_treat | olmesartan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | olmesartan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D006333 | Heart Failure | DISEASE | may_treat | olmesartan |
| MEDRT | D006929 | Hyperaldosteronism | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D006929 | Hyperaldosteronism | DISEASE | ci_with | olmesartan |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | olmesartan |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | olmesartan |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | olmesartan |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | olmesartan medoxomil |
| MEDRT | D018487 | Ventricular Dysfunction, Left | DISEASE | may_treat | olmesartan medoxomil |
| MEDRT | D018487 | Ventricular Dysfunction, Left | DISEASE | may_treat | olmesartan |
| MEDRT | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan medoxomil |
| MEDRT | N0000000070 | Angiotensin 2 Receptor Antagonists | MOA | has_moa | olmesartan |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | olmesartan |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | olmesartan |
| MEDRT | N0000008669 | Decreased Intravascular Volume | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008731 | Decreased Mineralocorticoid Secretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008731 | Decreased Mineralocorticoid Secretion | PE | has_pe | olmesartan |
| MEDRT | N0000008859 | Decreased Renal K+ Excretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000008859 | Decreased Renal K+ Excretion | PE | has_pe | olmesartan |
| MEDRT | N0000009553 | Increased Renal Na+ Excretion | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000009553 | Increased Renal Na+ Excretion | PE | has_pe | olmesartan |
| MEDRT | N0000009825 | Renal Arterial Vasoconstriction | PE | ci_pe | olmesartan medoxomil |
| MEDRT | N0000009825 | Renal Arterial Vasoconstriction | PE | ci_pe | olmesartan |
| MEDRT | N0000009826 | Renal Arterial Vasodilation | PE | has_pe | olmesartan medoxomil |
| MEDRT | N0000009826 | Renal Arterial Vasodilation | PE | has_pe | olmesartan |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | ATC | C09CA08 |
| CODES | SNOMEDCT | 412260006 |
| CODES | USP | m887 |
| CODES | VUID | 4021345 |
| SOURCES | Source | Anatomical Therapeutic Chemical |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |